AKAlina Koshelyuk

Alina Koshelyuk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alina Koshelyuk has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic performance of circulating microRNAs for the early diagnosis of different types of acute cerebrovascular disease

    by Sharbanu Battakova, Marina Grigolashvili, Irina Kadyrova, Dmitry Kasatkin, Mira Beisembayeva, Shynar Muratbekova, Yelena Shayakhmetova, Altyn Bakenova, Alina Koshelyuk

    Early differentiation of acute cerebrovascular conditions is important for timely clinical management, while blood-based markers that could complement established diagnostic approaches remain under investigation. This exploratory case-control study evaluated the circulating expression and diagnostic performance of seven candidate microRNAs (miRNAs) in acute ischemic stroke (AIS), hemorrhagic stroke (HS), and transient ischemic attack (TIA) during the first 12 h after symptom onset. The study included 200 participants: 50 patients with AIS, 50 with HS, 50 with TIA, and 50 controls. Plasma was collected from the clinical groups at 3–4.5 h and 12 h after symptom onset and from controls at a single time point. Expression levels of let-7e-5p, miR-21-5p, miR-107, miR-125b-5p, miR-130a-3p, miR-143-3p, and miR-222-3p were measured using real-time quantitative polymerase chain reaction (RT-qPCR). Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis and binary logistic regression. let-7e-5p showed the most consistent expression pattern, with lower levels in AIS, HS, and TIA than in controls at both sampling time points. miR-107 was lower in AIS and HS than in controls at both time points, whereas miR-125b-5p showed a predominantly AIS-related pattern. Among comparisons with controls, let-7e-5p yielded the highest individual area under the ROC curve (AUC), reaching 0.867 for AIS at 12 h, whereas miR-222-3p yielded the highest individual AUC for AIS versus HS (0.833 at 12 h). Multi-miRNA models did not significantly improve discrimination over the best-performing individual markers. In the complete-case subset, adding let-7e-5p to a model comprising routinely available clinical variables was associated with a higher AUC for AIS versus controls (0.982) than either component alone. Overall, the observed expression and discrimination patterns support further investigation of circulating miRNAs as complementary markers in acute cerebrovascular disease. Prospective evaluation in larger, independent cohorts, including patients with stroke-mimicking conditions, is needed to determine their diagnostic performance and incremental value in real-world clinical settings.

  • Open Access

    Comorbidity Burden and Early In‐Hospital Outcomes After Intravenous Thrombolysis for Acute Ischemic Stroke

    by Sharbanu Battakova, Marina Grigolashvili, Dmitry Kasatkin, Irina Kadyrova, Yelena Shayakhmetova, Mira Beisembayeva, Shynar Muratbekova, Ivan Turkevich, Alina Koshelyuk

    Background: The prognostic relevance of comorbidity burden in patients with acute ischemic stroke (AIS) treated with intravenous thrombolysis (IVT) remains uncertain. This study examined the association between four comorbidity indices and early in‐hospital outcomes. Methods: This single‐center retrospective study included 106 patients with AIS treated with IVT between January and December 2024. Comorbidity burden was assessed using the Charlson Comorbidity Index (CCI; 1987 and 2011 versions) and the Elixhauser Comorbidity Index (ECI; 2009 and 2017 versions). The primary outcome was unfavorable functional status at discharge, defined as a modified Rankin scale (mRS) score of 3–6. Multivariable logistic regression was used to identify factors associated with the primary outcome, and receiver operating characteristic (ROC) analyses assessed the discriminatory performance of the indices. Mortality comparisons were exploratory because only 10 in‐hospital deaths occurred. Results: The median age was 68 years, and 60 patients (56.6%) were men. Unfavorable functional outcome (mRS 3–6) occurred in 73 patients (68.9%). Higher admission National Institutes of Health Stroke Scale (NIHSS) scores and glucose levels were independently associated with unfavorable functional status at discharge, whereas none of the four comorbidity indices remained significant after multivariable adjustment. The comorbidity indices showed limited to modest discriminatory performance, with an AUC of 0.645 (95% CI 0.531–0.760) for CCI 1987. Hemorrhagic transformation (HT) occurred exclusively in patients with an unfavorable outcome and was more frequent among nonsurvivors. Exploratory comparisons also showed higher prestroke mRS, admission NIHSS, CCI 1987, and CCI 2011 scores among nonsurvivors; no multivariable mortality analysis was performed. Conclusions: None of the evaluated comorbidity indices was independently associated with functional status at hospital discharge. Their discriminatory performance was modest, whereas admission stroke severity and glucose level showed stronger associations with short‐term outcome. Given the retrospective single‐center design, modest sample size, and limited number of deaths, the findings should be considered exploratory and hypothesis‐generating and require confirmation in larger prospective studies.

  • Open Access

    Evaluation of Stroke Care Delivery: 12‐Month Experience of a Tertiary Stroke Center in Central Asia

    by Marina Grigolashvili, Dmitriy Klyuyev, Dmitry Kasatkin, Sharbanu Battakova, Yelena Shayakhmetova, Mira Beisembayeva, Shynar Muratbekova, Alina Koshelyuk, Yessenbay Baituyak, Ivan Turkevich, et al.

    The present study is a retrospective analysis of the activities of a tertiary stroke center (SC) operating on the basis of Akzhan Clinic in Karaganda Region during the year 2024. The primary objective of this study was to examine the epidemiological features, the structure of stroke morbidity, and the efficacy of thrombolytic therapy (TLT) in patients with ischemic stroke (IS). The study included data from a total of 585 patients, out of which 437 had been hospitalized with acute cerebrovascular disorders, and 104 of these patients had received TLT for IS. The analysis revealed a high level of utilization of TLT (23.8%), which was significantly higher than the average regional and national figures, owing to the efficient organization of prehospital and in‐hospital stages, availability of skilled personnel, and a state‐of‐the‐art technical infrastructure. Additionally, mechanical thrombectomy (MT) was performed in 100 instances, further confirming the high level of adoption of advanced treatment modalities. The proportion of hemorrhagic transformations (7.69%) and mortality (6.7%) was comparable to or lower than international benchmarks. The results demonstrate the high effectiveness of the performance of the SC “Akzhan” and the need for the further expansion of similar facilities in order to improve the accessibility and quality of stroke treatment in Kazakhstan.